Valuation (3%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -14.34 | N/A |
PEG Ratio (TTM) | -1.39 | N/A |
P/S Ratio (TTM) | 2.46 | N/A |
P/B Ratio (TTM) | 3.99 | N/A |
P/FCF Ratio (TTM) | -33.81 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -14.73% | N/A |
ROE (TTM) | -26.72% | N/A |
Net Profit Margin (TTM) | -17.13% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 0.08% | -739.73% | N/A |
Revenue | 0.11% | 13.64% | N/A |
Net Income | -0.45% | -675.04% | N/A |
Cash Flow | -564.73% | -2,173.39% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.14 | N/A |
Quick Ratio (TTM) | 3.67 | N/A |
D/E Ratio (TTM) | 0.66 | N/A |
Interest Coverage (TTM) | -4.27 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |